Anterix (NASDAQ:ATEX) vs. IHS (NYSE:IHS) Financial Review

Anterix (NASDAQ:ATEXGet Free Report) and IHS (NYSE:IHSGet Free Report) are both computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, profitability, analyst recommendations, risk, institutional ownership and dividends.

Insider & Institutional Ownership

87.7% of Anterix shares are held by institutional investors. Comparatively, 17.5% of IHS shares are held by institutional investors. 45.6% of Anterix shares are held by company insiders. Comparatively, 1.1% of IHS shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Anterix and IHS’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Anterix 1,370.92% -12.26% -6.55%
IHS 8.12% -661.41% 12.24%

Valuation & Earnings

This table compares Anterix and IHS”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Anterix $6.03 million 125.46 -$11.37 million $4.35 9.29
IHS $1.58 billion 1.76 $143.60 million $0.41 20.21

IHS has higher revenue and earnings than Anterix. Anterix is trading at a lower price-to-earnings ratio than IHS, indicating that it is currently the more affordable of the two stocks.

Volatility & Risk

Anterix has a beta of 0.7, indicating that its share price is 30% less volatile than the S&P 500. Comparatively, IHS has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Anterix and IHS, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Anterix 0 2 1 0 2.33
IHS 2 4 3 0 2.11

Anterix currently has a consensus price target of $50.00, suggesting a potential upside of 23.79%. IHS has a consensus price target of $9.61, suggesting a potential upside of 15.96%. Given Anterix’s stronger consensus rating and higher probable upside, equities analysts plainly believe Anterix is more favorable than IHS.

Summary

Anterix beats IHS on 8 of the 14 factors compared between the two stocks.

About Anterix

(Get Free Report)

Anterix Inc. operates as a wireless communications company. The company focuses on commercializing its spectrum assets to enable the targeted utility and critical infrastructure customers to deploy private broadband networks and innovative broadband solutions. It holds licensed spectrum in the 900 MHz band with coverage throughout the United States, Alaska, Hawaii, and Puerto Rico. The company was formerly known as pdvWireless, Inc. and changed its name to Anterix Inc. in August 2019. Anterix Inc. was incorporated in 1997 and is headquartered in Woodland Park, New Jersey.

About IHS

(Get Free Report)

IHS Inc. develops source of information, insight and analytics in different areas of business. The Company’s segments include Resources, Transportation and Consolidated Markets & Solutions. The Company’s Resources segment includes its Energy and Chemicals product offerings. Its Transportation segment includes its Automotive; Maritime & Trade, and Aerospace, Defense & Security product offerings. Its Consolidated Markets & Solutions segment includes its Product Design; Technology, Media & Telecom, and Economics & Country Risk product offerings. It provides authoritative analysis and forecasts of sales and production for light vehicles, medium and heavy commercial vehicles, powertrain, components and technology systems across various markets. Its product design offerings include content and analysis on various engineering and technical standards, codes, reference books, journals, and other scientific and technical documents, as well as software-based engineering decision engines.

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.